Emerging Clinical Diagnostics Laboratory – Built for Scale | $4–$5M Revenue Growth Potential

This is a rare opportunity to acquire a fully credentialed clinical medical laboratory in its early growth stage, strategically positioned to scale to $4–$5 million in annual revenue within the next 24 months under focused business development and payer expansion.

Importantly, this is not a startup — the lab is fully operational with infrastructure, licensing, equipment, and compliance foundations already in place. Replicating this build-out from scratch would conservatively exceed $4 million in capital investment, making this a true replacement-cost acquisition with substantial upside.

Business Overview

This clinical laboratory provides a wide range of diagnostic testing services used by healthcare providers to diagnose, monitor, and screen for health conditions. The lab is:

• Registered with an active NPI (National Provider Identifier)
• Operating under CLIA certification
• Approved to perform regulated clinical laboratory testing

The platform is structured for expansion rather than stabilization, presenting a growth-oriented acquisition opportunity.

Services & Capabilities

The lab currently offers a broad testing menu, including:

• Genetic and molecular diagnostics
• Routine clinical testing
• Clinical toxicology
• Allergy testing
• COVID-19 testing

Regulatory approvals allow testing across multiple disciplines, including:

• Bacteriology
• Clinical chemistry
• Immunology (serology)
• Endocrinology
• Hematology
• Toxicology
• Urinalysis
• Virology

This diversified testing capability supports scalability across multiple provider verticals.

Clinical Credentials

The laboratory team includes:

• Board-certified pathologists
• Ph.D.-level professionals in molecular diagnostics
• Qualified clinical laboratory personnel

The lab emphasizes competitive turnaround times and flexible provider ordering/reporting systems, creating a scalable, provider-facing platform.

Location & Market

Located in Central New Jersey, servicing healthcare providers throughout New York and New Jersey — two of the most regulated and high-value healthcare markets in the country.

Growth Opportunity – Asset Sale

This lab is operationally early-stage but fully built structurally. Key growth drivers include:

• Expansion of provider network
• Increased specimen volume
• Strategic payer contracting
• Sales force deployment
• Targeted specialty testing expansion

With proper capitalization and business development, the platform is positioned for significant near-term revenue growth.

Ideal Buyer

This opportunity is ideal for:

• Strategic laboratory operators
• Healthcare investors
• Private equity groups
• Physician groups seeking vertical integration
• Healthcare consolidators

This is a confidential offering. Detailed financials, payer mix, equipment schedules, and regulatory documentation are available upon signed NDA.